Other psychoactive substance dependence with withdrawal, uncomplicated
ICD-10 F19.230 is a billable code used to indicate a diagnosis of other psychoactive substance dependence with withdrawal, uncomplicated.
F19.230 refers to a diagnosis of dependence on other psychoactive substances, characterized by a pattern of compulsive use despite harmful consequences, and the presence of withdrawal symptoms when the substance is reduced or discontinued. This code is used when the withdrawal symptoms are uncomplicated, meaning they do not require hospitalization or intensive medical intervention. Common substances that may fall under this category include synthetic cannabinoids, hallucinogens, and other non-specified psychoactive substances. Clinically, patients may present with symptoms such as anxiety, irritability, insomnia, and physical symptoms like tremors or sweating. Treatment typically involves supportive care, counseling, and possibly medication to manage withdrawal symptoms. It is crucial for healthcare providers to document the specific substance involved, the severity of dependence, and the withdrawal symptoms to ensure accurate coding and appropriate treatment planning.
Detailed history of substance use, withdrawal symptoms, and treatment plan.
Patients presenting with withdrawal symptoms after cessation of use, requiring outpatient management.
Ensure accurate documentation of the specific substance and severity of dependence.
Comprehensive psychiatric evaluation, including mental health history and current symptoms.
Patients with co-occurring mental health disorders and substance dependence.
Document any psychiatric interventions or medications prescribed for withdrawal management.
Used for patients receiving counseling for substance dependence.
Document the counseling session details and patient progress.
Addiction specialists may use this code frequently in conjunction with F19.230.
F19.230 includes dependence on various psychoactive substances not specifically classified elsewhere, such as synthetic cannabinoids, hallucinogens, and other non-specified substances.
